| Target Price | kr652.80 |
| Price | kr530.00 |
| Potential |
23.17%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target MedCap AB 2027 .
The average MedCap AB target price is kr652.80.
This is
23.17%
register free of charge
kr693.00
30.75%
register free of charge
kr626.20
18.15%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend MedCap AB to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the MedCap AB stock has an average upside potential 2027 of
23.17%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion kr | 2.11 | 2.43 |
| 16.68% | 15.13% | |
| EBITDA Margin | 21.64% | 22.78% |
| 0.85% | 5.26% | |
| Net Margin | 10.43% | 10.86% |
| 9.17% | 4.15% |
4 Analysts have issued a sales forecast MedCap AB 2026 . The average MedCap AB sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an MedCap AB EBITDA forecast 2026. The average MedCap AB EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 MedCap AB Analysts have issued a net profit forecast 2026. The average MedCap AB net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share kr | 14.65 | 17.60 |
| 4.72% | 20.14% | |
| P/E | 30.69 | |
| EV/Sales | 3.42 |
3 Analysts have issued a MedCap AB forecast for earnings per share. The average MedCap AB EPS is
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


